Motus GI Holdings PE Ratio 2016-2023 | MOTS
Current and historical p/e ratio for Motus GI Holdings (MOTS) from 2016 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Motus GI Holdings PE ratio as of May 10, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Motus GI Holdings PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-04-15 | 0.17 | 0.00 | |
| 2023-12-31 | 1.28 | $-28.55 | 0.00 |
| 2023-09-30 | 6.75 | $-35.91 | 0.00 |
| 2023-06-30 | 10.05 | $-56.97 | 0.00 |
| 2023-03-31 | 14.60 | $-78.86 | 0.00 |
| 2022-12-31 | 12.60 | $-92.05 | 0.00 |
| 2022-09-30 | 36.75 | $-110.20 | 0.00 |
| 2022-06-30 | 84.48 | $-114.84 | 0.00 |
| 2022-03-31 | 107.97 | $-116.94 | 0.00 |
| 2021-12-31 | 140.10 | $-164.92 | 0.00 |
| 2021-09-30 | 206.85 | $-170.92 | 0.00 |
| 2021-06-30 | 312.00 | $-179.91 | 0.00 |
| 2021-03-31 | 363.00 | $-194.90 | 0.00 |
| 2020-12-31 | 284.40 | $-188.91 | 0.00 |
| 2020-09-30 | 293.22 | $-212.90 | 0.00 |
| 2020-06-30 | 396.00 | $-227.89 | 0.00 |
| 2020-03-31 | 202.14 | $-260.87 | 0.00 |
| 2019-12-31 | 687.00 | $-278.86 | 0.00 |
| 2019-09-30 | 594.00 | $-320.84 | 0.00 |
| 2019-06-30 | 909.00 | $-365.82 | 0.00 |
| 2019-03-31 | 1170.00 | $-368.82 | 0.00 |
| 2018-12-31 | 933.00 | $-452.78 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.000B | $0.000B |
| Motus GI Holdings, Inc. is a medical technology company. It focuses on the development and commercialization of the Pure-Vu(R) System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company also operates through subsidiaries in the U.S. and Israel. Motus GI Holdings, Inc. is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $38.069B | 20.90 |
| Inspire Medical Systems (INSP) | United States | $4.986B | 0.00 |
| Axonics (AXNX) | United States | $3.440B | 0.00 |
| 10x Genomics (TXG) | United States | $3.097B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.080B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.900B | 0.00 |
| Enovis (ENOV) | United States | $2.801B | 20.76 |
| Azenta (AZTA) | United States | $2.782B | 156.36 |
| Hims & Hers Health (HIMS) | United States | $2.640B | 0.00 |
| Privia Health (PRVA) | United States | $2.144B | 119.80 |
| Schrodinger (SDGR) | United States | $1.652B | 0.00 |
| Omnicell (OMCL) | United States | $1.383B | 47.81 |
| Phreesia (PHR) | United States | $1.205B | 0.00 |
| Standard BioTools (LAB) | United States | $0.696B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.651B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.627B | 0.00 |
| Talkspace (TALK) | United States | $0.477B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.406B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.378B | 0.00 |
| Pulmonx (LUNG) | United States | $0.326B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.306B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.215B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.212B | 0.00 |
| Outset Medical (OM) | United States | $0.159B | 0.00 |
| American Well (AMWL) | United States | $0.139B | 0.00 |
| TruBridge (TBRG) | United States | $0.129B | 7.07 |
| MSP Recovery (LIFW) | United States | $0.121B | 0.00 |
| Augmedix (AUGX) | United States | $0.109B | 0.00 |
| 111 (YI) | China | $0.095B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.078B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.061B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| Movano (MOVE) | United States | $0.043B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.034B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| CareCloud (CCLD) | United States | $0.020B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |